06:06 AM EDT, 06/20/2025 (MT Newswires) -- Eli Lilly and Company ( LLY ) said the response from the Indian market for its diabetes and weight-loss drug Mounjaro has been "positive", Reuters reported Friday.
Lilly has sold more than 81,570 Mounjaro units in the South Asian country, Reuters reported, citing data from PharmaTrac.
Eli Lilly ( LLY ) did not immediately respond to MTNewswires' request for a copy of the statement.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)